---
title: Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate
  cytotoxic reprogramming of PD-1<sup>+</sup>CD8<sup>+</sup> T cells
date: '2024-12-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39702858/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241220170926&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: The mechanisms underlying the efficacy of anti-programmed cell death
  protein 1 (PD-1) and anti-cytotoxic T lymphocyte-associated protein 4 (CTLA-4) therapy
  are incompletely understood. Here, by immune profiling responding PD-1^(+)CD8^(+)
  T (T(Resp)) cell populations from patients with advanced melanoma, we identified
  differential programming of T(Resp) cells in response to combination therapy, from
  an exhausted toward a more cytotoxic effector program. This effect does not occur
  with ...
disable_comments: true
---
The mechanisms underlying the efficacy of anti-programmed cell death protein 1 (PD-1) and anti-cytotoxic T lymphocyte-associated protein 4 (CTLA-4) therapy are incompletely understood. Here, by immune profiling responding PD-1^(+)CD8^(+) T (T(Resp)) cell populations from patients with advanced melanoma, we identified differential programming of T(Resp) cells in response to combination therapy, from an exhausted toward a more cytotoxic effector program. This effect does not occur with ...